Abstract
Our aim was to prospectively investigate the impact of Behçet’s disease (BD), disease activity, and clinical and demographic characteristics on different aspects of quality of life (QoL) measured by the short-form (SF)-36 QoL scale. We administered the SF-36 to 37 consecutive BD patients in different moments of disease activity, and to 23 healthy controls (HC). The eight subcategories of the SF-36 underwent statistical analysis for identifying differences and correlations. Compared to HC, BD patients showed significantly lower mean scores in all SF-36 QoL subscales except mental health and role-emotional. Females showed a poorer QoL compared to males. Disease activity evaluated by the BD Current Activity Form inversely correlated with physical functioning (ρ = −0.68, p < 0.0001), bodily pain (ρ = −0.68, p < 0.0001), role-physical (ρ = −0.64, p < 0.0001), vitality (ρ = −0.64, p < 0.0001), general health (ρ = −0.64, p < 0.0001), social functioning (ρ = −0.50, p = 0.0002), mental health (ρ = −0.48, p = 0.0004), and role-emotional (ρ = −0.40, p = 0.003). Mucosal, central nervous system (CNS), musculoskeletal and ocular manifestations were the main factors that negatively affected QoL in BD. For ocular disease, physical functioning was significantly impaired in patients with panuveitis compared to other ocular manifestations (p = 0.0002). Best-corrected visual acuity was inversely correlated with social functioning (ρ = −0.53, p < 0.0001), role-physical (ρ = −0.48, p < 0.0001), bodily pain (ρ = −0.46, p = 0.02), and mental health (ρ = −0.43, p < 0.0001). Patients with BD have a poorer QoL compared to HC, particularly for women, while the decline of QoL is closely related to the overall disease activity of BD. Single organ involvements may affect independently specific SF-36 subscales, especially mucosal, CNS, musculoskeletal, and ocular manifestations.
Similar content being viewed by others
References
Cantarini L, Lopalco G, Selmi C et al (2015) Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev 14:90–97. doi:10.1016/j.autrev.2014.10.005
Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148–155
Neves FS, Moraes JC, Kowalski SC, Goldenstein-Schainberg C, Lage LV, Gonçalves CR (2007) Cross-cultural adaptation of the Behçet’s Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 26:1263–1267. doi:10.1007/s10067-006-0484-y
Emmi G, Silvestri E, Squatrito D et al (2014) Behçet’s syndrome pathophysiology and potential therapeutic targets. Intern Emerg Med 9:257–265. doi:10.1007/s11739-013-1036-5
Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656–1662. doi:10.1136/ard.2007.080432
Vitale A, Emmi G, Lopalco G et al (2017) Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study. Clin Rheumatol 36(2):451–455. doi:10.1007/s10067-016-3417-4
Ertam I, Kitapcioglu G, Aksu K et al (2009) Quality of life and its relation with disease severity in Behçet’s disease. Clin Exp Rheumatol 27:S18–S22
Blackford S, Finlay AY, Roberts DL (1997) Quality of life in Behçet’s syndrome: 335 patients surveyed. Br J Dermatol 136:293
Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG (1999) Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behçet’s disease. Int J Colorectal Dis 14:52–57
Bodur H, Borman P, Ozdemir Y, Atan C, Kural G (2006) Quality of life and life satisfaction in patients with Behçet’s disease: relationship with disease activity. Clin Rheumatol 25:329–333
Tanriverdi N, Taşkintuna Dürü C, Ozdal P, Ortaç S, Firat E (2003) Health-related quality of life in Behçet patients with ocular involvement. Jpn J Ophthalmol 47:85–92
Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R (2006) Arthropathy, quality of life, depression, and anxiety in Behcet’s disease: relationship between arthritis and these factors. Clin Rheumatol 25:524–531. doi:10.1007/s10067-005-0100-6
Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U (2006) Oral health related quality of life is affected by disease activity in Behçet’s disease. Oral Dis 12:145–151. doi:10.1111/j.1601-0825.2005.01173.x
Uğuz F, Dursun R, Kaya N, Cilli AS (2007) Quality of life in patients with Behçet’s disease: the impact of major depression. Gen Hosp Psychiatry 29:21–24. doi:10.1016/j.genhosppsych.2006.10.001
Moses Alder N, Fisher M, Yazici Y (2008) Behçet’s syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol 26:S110–S113
Mumcu G, Niazi S, Stewart J et al (2009) Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet’s disease. J Oral Pathol Med 38:406–409. doi:10.1111/j.1600-0714.2009.00752.x
Alibaz-Oner F, Aldag B, Aldag M et al (2016) Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet’s disease. J Vasc Surg Venous Lymphat Disord 4:301–306. doi:10.1016/j.jvsv.2016.01.003
Melikoğlu M, Melikoglu MA (2014) What affects the quality of life in patients with Behcet’s disease? Acta Reumatol Port 39:46–53
Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F (2010) Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford) 49:2165–2171. doi:10.1093/rheumatology/keq251
Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036
McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–263
International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347. doi:10.1111/jdv.12107
McGrath C, Bedi R (2000) Gender variations in the social impact of oral health. J Ir Dent Assoc 46:87–91
Yazici H, Tüzün Y, Pazarli H et al (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43:783–789
Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
Vitale A, Emmi G, Lopalco G et al (2017) Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease. Clin Rheumatol. doi:10.1007/s10067-017-3627-4 (Epub ahead of print)
Senusi A, Seoudi N, Bergmeier LA, Fortune F (2015) Genital ulcer severity score and genital health quality of life in Behçet’s disease. Orphanet J Rare Dis 10:117. doi:10.1186/s13023-015-0341-7
Mumcu G, Sur H, Inanc N et al (2009) A composite index for determining the impact of oral ulcer activity in Behcet’s disease and recurrent aphthous stomatitis. J Oral Pathol Med 38:785–791. doi:10.1111/j.1600-0714.2009.00803.x
Naito M, Suzukamo Y, Wakai K et al (2014) One-year period prevalence of oral aphthous ulcers and oral health-related quality of life in patients with Behçet’s disease. Genet Res Int 2014:930348. doi:10.1155/2014/930348
Canpolat O, Yurtsever S (2011) The quality of life in patients with Behçet’s disease. Asian Nurs Res (Korean Soc Nurs Sci) 5:229–235
Garip Y, Öztaş D, Güler T (2016) Prevalence of fibromyalgia in Turkish geriatric population and its impact on quality of life. Agri 28:165–170. doi:10.5505/agri.2016.48243
Abdelraheem T, Habib HM, Eissa AA, Radwan NM (2013) Psychiatric disorders and MRI brain findings in patients with systemic lupus erythematosus and Behcet’s disease: a cross sectional study. Acta Reumatol Port 38:252–260
Melikoglu MA, Melikoglu M (2010) The relationship between disease activity and depression in patients with Behcet disease and rheumatoid arthritis. Rheumatol Int 30:941–946. doi:10.1007/s00296-009-1080-7
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
All patients enrolled gave their informed consent for participating in the study.
Rights and permissions
About this article
Cite this article
Fabiani, C., Vitale, A., Orlando, I. et al. Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study. Intern Emerg Med 12, 947–955 (2017). https://doi.org/10.1007/s11739-017-1691-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1691-z